Cidara Therapeutics
CDTX
CDTX
44 hedge funds and large institutions have $25.2M invested in Cidara Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
36% less capital invested
Capital invested by funds: $39.5M → $25.2M (-$14.2M)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Holders
44
Holding in Top 10
1
Calls
$41K
Puts
–
Top Buyers
| 1 | +$307K | |
| 2 | +$174K | |
| 3 | +$154K | |
| 4 |
DMKJ
David M. Knott Jr
|
+$125K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$78.6K |
Top Sellers
| 1 | -$327K | |
| 2 | -$263K | |
| 3 | -$252K | |
| 4 |
Two Sigma Investments
New York
|
-$195K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$185K |